Diabetic retinopathy is the leading cause of blindness in working-age adults, affecting millions of Americans today. What’s even more worrisome is that primary-care practices can prevent vision loss caused by diabetic retinopathy, but many don’t have the equipment to run assessment tests. It’s high time the medical industry becomes aware there’s now new technology that can save patients’ vision, and it’s incredibly easy and cost-effective to use.
The Welch Allyn RetinaVue Network is an affordable and effective diabetic retinopathy screening tool that can double patient-compliance rates in just 12 months. It involves an incredibly simple four-step process, which is outlined below.
- Acquire: After entering required patient information, use the RetinaVue RV 100 Imager to acquire images of each eye. You’ll know the image is successful when the green checkmark appears on the camera. Remember to save the good-quality images.
- Transfer: Place the RV 100 Imager in the docking station and click “Submit Exam” to transfer images.
- Analyze: After transferring images, a board-certified retinal specialist will evaluate the exam. The specialist will identify, classify and document all levels of diabetic retinopathy.
- Report: A diagnostic report provided by the retinal specialist will be returned that same day. This report includes the patient information, images, a diagnostic report and referral/screening plan.
Patients shouldn’t have to suffer from vision loss caused by diabetic retinopathy, a highly treatable condition. Bring the Welch Allyn RetinaVue Network into your primary-care practice to improve patient care and earn in more revenue. You can visit Medical Device Depot today to learn more.